Pharma

Healthcare Platform HealthUno Targets 25% Share in Online Doctor Consultation Space by 2025

Healthcare Platform HealthUno Targets 25% Share in Online Doctor Consultation Space by 2025

Press Trust of India | Tuesday March 15, 2022, Chennai

The Chennai-based healthcare consultation platform, HealthUno trains its eyes on a 25 per cent market share in India by 2025.

Dr Reddy's Plans 'Business Continuity' In Russia

Dr Reddy's Plans 'Business Continuity' In Russia

Wednesday March 09, 2022, New Delhi

Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days.

Pharma Industry To Grow By 9% To 11% In 2021-22: ICRA

Pharma Industry To Grow By 9% To 11% In 2021-22: ICRA

Edited by Animesh Singh | Tuesday January 04, 2022, New Delhi

ICRA has said that the pharmaceutical industry is estimated to grow at the rate of 9 per cent to 11 per cent in 2021-22 due to emerging markets

Lupin Receives Inspection Report From USFDA For Goa Manufacturing Facility

Lupin Receives Inspection Report From USFDA For Goa Manufacturing Facility

Press Trust of India | Tuesday December 14, 2021, New Delhi

The USFDA has determined that the inspection classification of the facility is VAI, the company said in a statement.

Government Notifies Facilities in Pune And Hyderabad For Covid Vaccine Testing

Government Notifies Facilities in Pune And Hyderabad For Covid Vaccine Testing

Edited by Animesh Singh | Sunday July 04, 2021

To ramp up testing and quality control of Coronavirus vaccines, the Centre has notified two testing facilities in Pune and Hyderabad for the purpose.

Zydus Cadila Applies For Emergency Use Nod For Covid-19 Vaccine

Zydus Cadila Applies For Emergency Use Nod For Covid-19 Vaccine

Reuters | Thursday July 01, 2021

An approval for Zydus' vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in the country.

From May 1, Pay More For Second Jab Of Covishield

From May 1, Pay More For Second Jab Of Covishield

Reported by Animesh Singh | Wednesday April 21, 2021

COVID-19 vaccine: From May 1, 2021, a jab of Serum Institute of India's Covishield vaccine will cost Rs 600 in private hospitals.

India's New Unicorn Is EPharmacy

India's New Unicorn Is EPharmacy

Saritha Rai, Bloomberg | Wednesday April 07, 2021

API Holdings Pvt said it will use funds to expand its network and add more tele-consultations to link up customers with the 60,000 brick-and-mortar pharmacies and 4,000 doctors it already has on its books.

Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India

Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India

Reuters | Monday April 05, 2021

A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said.

Indian Pharma Firms Go Local Seeking To End Reliance On China

Indian Pharma Firms Go Local Seeking To End Reliance On China

Reuters | Tuesday February 23, 2021

Indian Pharma Firms: Although India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019 from nearly nothing three decades ago

Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V

Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V

Edited by Nirmalya Sen | Friday February 19, 2021

Dr Reddy's will present the safety profile of phase two study and interim data of phase three study which is expected to completed by February 21

AstraZeneca Shares Up 4% On WHO's Emergency Use Approval Of Covid-19 Vaccine

AstraZeneca Shares Up 4% On WHO's Emergency Use Approval Of Covid-19 Vaccine

Edited by Nirmalya Sen | Tuesday February 16, 2021

WHO's move widens access to the relatively inexpensive shot in the developing world

Dr. Reddy's Laboratories Q3 Profit At Rs 20 Crore

Dr. Reddy's Laboratories Q3 Profit At Rs 20 Crore

Edited by Nirmalya Sen | Friday January 29, 2021

Revenue for the third quarter came at Rs 4,930 crore, which was up 12 per cent year-over-year and 1 per cent quarter-over-quarter

Sun Pharma Q3 Profit Doubles To Rs 1,852.5 Crore

Sun Pharma Q3 Profit Doubles To Rs 1,852.5 Crore

Edited by Nirmalya Sen | Friday January 29, 2021

The pharma major reported a net profit of Rs 1,852.5 crore in Q3FY21

Novavax Claims Covid-19 Vaccine 89% Effective In UK Trial, Less In South Africa, Shares Jump

Novavax Claims Covid-19 Vaccine 89% Effective In UK Trial, Less In South Africa, Shares Jump

Edited by Nirmalya Sen | Friday January 29, 2021

Serum Institute Of India has applied to conduct local trial for Novavax vaccine

1234...5